Fibrocell Science (FCSC) Reports Positive Feedback from Type B End-of-Phase 2 Meeting with FDA on Phase 3 Clinical Trial Design for FCX-007 Mar 27, 2019 07:32AM
Fibrocell Science (FCSC) Announces Interim Results and Progress of Phase 1/2 Clinical Trial of FCX-007 Gene Therapy May 21, 2018 07:01AM
Fibrocell Science (FCSC) Announces FDA Allowance of IND for FCX-013 for Treatment of Moderate to Severe Localized Scleroderma Mar 6, 2018 08:04AM
Fibrocell Science (FCSC) Reports FDA Allowance to Initiate Pediatric Enrollment in Phase 1/2 Clinical Trial of FCX-007 for the Treatment of RDEB Jan 30, 2018 08:04AM
Fibrocell Science (FCSC) Reports Interim Results of Phase 1/2 Clinical Trial of FCX-007 Gene Therapy for RDEB Sep 26, 2017 08:03AM


Nov 10, 2016 08:39AM Fibrocell Science (FCSC) Names New Chief Medical Advisor